Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * FARRELL PETER C	2. Issuer Name and Ticker or Trading Symbol RESMED INC [ RMD ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __ X __ Director                      _____ 10% Owner __ X __ Officer (give title below)      _____ Other (specify below) Chairman of the Board
(Last)          (First)          (Middle) RESMED INC., 9001 SPECTRUM CENTER BOULEVARD	3. Date of Earliest Transaction (MM/DD/YYYY) 4/1/2015
(Street) SAN DIEGO, CA 92123 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
ResMed Common Stock	4/1/2015		M (1)		13557	A	$15.52	382156	D
ResMed Common Stock	4/1/2015		S (1)		13357	D	$70.6881   (3)	368799	D
ResMed Common Stock	4/1/2015		S (1)		200	D	$71.245   (4)	368599	D
ResMed Common Stock	4/1/2015		M (1)		24443	A	$19.25	391042	D
ResMed Common Stock	4/1/2015		S (1)		22143	D	$70.6876   (5)	368599	D
ResMed Common Stock	4/1/2015		S (1)		300	D	$71.28   (6)	368599	D
ResMed Common Stock								22783	I	Peter C. Farrell Grantor Retained Trust dated December 2012   (7)
ResMed Common Stock								87776	I	Peter C. Farrell Grantor Retained Annuity Trust dated March 4, 2014   (1)
Resmed Common Stock								200000	I	Peter C. Farrell Grantor Retained Annuity Trust dated October 14, 2014   (7)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
ResMed Common Stock Options	$15.52	4/1/2015		M   (1)			13557	11/20/2009   (2)	11/20/2015	ResMed Commmon Stock	13557	$0	0	D
ResMed Common Stock Options	$19.25	4/1/2015		M   (1)			22443	2/3/2007   (2)	2/3/2016	ResMed Common Stock	22443	$0	207169	D

Explanation of Responses:
( 1)	The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
( 2)	Represents date options first became available. Options vest 1/4 each year.
( 3)	This transaction was executed in multiple trades at prices ranging from $70.09 to $71.02. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
( 4)	This transaction was executed in multiple trades at prices ranging from $70.09 to $71.40. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
( 5)	This transaction was executed in multiple trades at prices ranging from $70.08 to $71.02. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
( 6)	This transaction was executed in multiple trades at prices ranging from $71.12 to $71.59. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
( 7)	Securities held by Larry Poster, Trustee of the Peter C. Farrell Grantor Retained Annuity Trust.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
FARRELL PETER C RESMED INC. 9001 SPECTRUM CENTER BOULEVARD SAN DIEGO, CA 92123	X		Chairman of the Board

Signatures
Peter C. Farrell		4/3/2015
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.